BC
APLS

Brookfield Corp’s Apellis Pharmaceuticals APLS Stock Holding History

Brookfield Corp’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-61,414
Closed -$5.59M – 138
2023
Q2 		$5.59M Sell
61,414
-54,726
-47% -$4.72M 0.02% 251
2023
Q1 		$7.66M Buy
116,140
+49,914
+75% +$2.88M 0.03% 220
2022
Q4 		$3.42M Buy
66,226
+5,996
+10% +$318K 0.01% 327
2022
Q3 		$4.11M Buy
60,230
+25,890
+75% +$1.53M 0.02% 301
2022
Q2 		$1.55M Buy
34,340
+19,474
+131% +$888K 0.01% 452
2022
Q1 		$755K Buy
+14,866
New +$656K ﹤0.01% 526

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return